BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20029048)

  • 1. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.
    Barker JN; Scaradavou A; Stevens CE
    Blood; 2010 Mar; 115(9):1843-9. PubMed ID: 20029048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.
    Kurtzberg J; Prasad VK; Carter SL; Wagner JE; Baxter-Lowe LA; Wall D; Kapoor N; Guinan EC; Feig SA; Wagner EL; Kernan NA;
    Blood; 2008 Nov; 112(10):4318-27. PubMed ID: 18723429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.
    Brunstein CG; Cutler CS; DeFor TE; Kim H; Bejanyan N; Garfall A; Verneris MR; Chen YB; Warlick ED; Spitzer T; Miller JS; Antin JH; Weisdorf DJ; Soiffer R; Wagner JE; Ballen KK
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):126-133. PubMed ID: 27989929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
    Purtill D; Smith K; Devlin S; Meagher R; Tonon J; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Stevens CE; Barker JN
    Blood; 2014 Nov; 124(19):2905-12. PubMed ID: 25185264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How I treat: the selection and acquisition of unrelated cord blood grafts.
    Barker JN; Byam C; Scaradavou A
    Blood; 2011 Feb; 117(8):2332-9. PubMed ID: 21149636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
    Eapen M; Klein JP; Sanz GF; Spellman S; Ruggeri A; Anasetti C; Brown M; Champlin RE; Garcia-Lopez J; Hattersely G; Koegler G; Laughlin MJ; Michel G; Nabhan SK; Smith FO; Horowitz MM; Gluckman E; Rocha V; ; ;
    Lancet Oncol; 2011 Dec; 12(13):1214-21. PubMed ID: 21982422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
    Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
    Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
    Horwitz ME; Chao NJ; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McDonald C; Waters-Pick B; Stiff P; Wease S; Peled A; Snyder D; Cohen EG; Shoham H; Landau E; Friend E; Peleg I; Aschengrau D; Yackoubov D; Kurtzberg J; Peled T
    J Clin Invest; 2014 Jul; 124(7):3121-8. PubMed ID: 24911148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
    Brunstein CG; Gutman JA; Weisdorf DJ; Woolfrey AE; Defor TE; Gooley TA; Verneris MR; Appelbaum FR; Wagner JE; Delaney C
    Blood; 2010 Nov; 116(22):4693-9. PubMed ID: 20686119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies.
    Gupta AO; Wagner JE
    Front Pediatr; 2020; 8():570282. PubMed ID: 33123504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
    Eapen M; Klein JP; Ruggeri A; Spellman S; Lee SJ; Anasetti C; Arcese W; Barker JN; Baxter-Lowe LA; Brown M; Fernandez-Vina MA; Freeman J; He W; Iori AP; Horowitz MM; Locatelli F; Marino S; Maiers M; Michel G; Sanz GF; Gluckman E; Rocha V;
    Blood; 2014 Jan; 123(1):133-40. PubMed ID: 24141369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation.
    Tang B; Huang L; Liu H; Cheng S; Song K; Zhang X; Yao W; Ning L; Wan X; Sun G; Wu Y; Cheng J; Long Q; Sun Z; Zhu X
    Blood Adv; 2020 Aug; 4(16):3829-3839. PubMed ID: 32790845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan.
    Watanabe M; Kanda J; Volt F; Ruggeri A; Suzuki R; Rafii H; Kimura F; Cappelli B; Kondo E; Scigliuolo GM; Takahashi S; Kenzey C; Rivera-Franco MM; Okamoto S; Rocha V; Chevallier P; Sanz J; Fürst S; Cornelissen J; Milpied N; Uchida N; Sugio Y; Kimura T; Ichinohe T; Fukuda T; Mohty M; Peffault de Latour R; Atsuta Y; Gluckman E
    Blood Adv; 2024 Feb; 8(3):640-652. PubMed ID: 38100431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA haplotype frequencies and diversity in patients with hemoglobinopathies.
    Scigliuolo GM; Boukouaci W; Cappelli B; Volt F; Rivera Franco MM; Dhédin N; de Latour RP; Devalck C; Dalle JH; Castelle M; Hermine O; Chardin MO; Poiré X; Brichard B; Paillard C; Rafii H; Kenzey C; Wu CL; Bouassida J; Robin M; Raus N; Rocha V; Ruggeri A; Gluckman E; Tamouza R;
    EJHaem; 2023 Nov; 4(4):963-969. PubMed ID: 38024588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Stability of Cord Blood Units After 29 Years of Cryopreservation: Follow-Up Data From the José Carreras Cord Blood Bank.
    Liedtke S; Többen S; Gressmann H; Meyer A; Verde PE; Gluckman E; Kogler G
    Stem Cells Transl Med; 2024 Jan; 13(1):30-42. PubMed ID: 37936262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia.
    Borrill R; Poulton K; Wynn R
    Front Pediatr; 2023; 11():1232281. PubMed ID: 37780051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens.
    Wang J; Sanati F; Firoozmand A; Fu P; Kolk M; Reese-Koc J; de Lima M; Boughan K; Cooper B; Caimi P; Gallogly M; Otegbeye F; Tomlinson B; Metheny L
    Front Oncol; 2023; 13():1186532. PubMed ID: 37207167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real-world experience of a referral center.
    Sun Z; Hu Y; Ji Y; Liu X; Gong X; Feng Y; Liu H; Zhang W; Qi S; Shen Q; Song K; Geng L; Yao W; Wan X; Tang B; Zhu X; Sun G; Qiang P; Song Z; Chen J
    EJHaem; 2023 May; 4(2):470-475. PubMed ID: 37206286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
    Sanchez-Petitto G; Rezvani K; Daher M; Rafei H; Kebriaei P; Shpall EJ; Olson A
    Stem Cells Transl Med; 2023 Mar; 12(2):55-71. PubMed ID: 36779789
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.